Morgan Stanley’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
|
|||||
|
2025
Q1 | $407K | Buy |
|
|||||
|
2024
Q4 | $727K | Sell |
|
|||||
|
2024
Q3 | $3.19M | Sell |
|
|||||
|
2024
Q2 | $11.7M | Buy |
|
|||||
|
2024
Q1 | $6.75M | Buy |
|
|||||
|
2023
Q4 | $24.8K | Buy |
|
|||||
|
2023
Q3 | $22.2K | Hold |
|
|||||
|
2023
Q2 | $25.8K | Sell |
|
|||||
|
2023
Q1 | $26.3K | Buy |
|
|||||
|
2022
Q4 | $9.22K | Sell |
|
|||||
|
2022
Q3 | $23K | Buy |
|
|||||
|
2022
Q2 | $35K | Buy |
|
|||||
|
2022
Q1 | $64K | Sell |
|
|||||
|
2021
Q4 | $1.28M | Sell |
|
|||||
|
2021
Q3 | $2.72M | Buy |
|
|||||
|
2021
Q2 | $4.74M | Sell |
|
|||||
|
2021
Q1 | $7.8M | Buy |
|
|||||
|
2020
Q4 | $939K | Buy |
|
|||||
|
2020
Q3 | $1.32M | Sell |
|
|||||
|
2020
Q2 | $11.3M | Buy |
|
|||||
|
2020
Q1 | $4.06M | Sell |
|
|||||
|
2019
Q4 | $4.29M | Sell |
|
|||||
|
2019
Q3 | $4.41M | Sell |
|
|||||
|
2019
Q2 | $6.45M | Sell |
|
|||||
|
2019
Q1 | $6.55M | Buy |
|
|||||
|
2018
Q4 | $5.26M | Buy |
|
|||||
|
2018
Q3 | $6.66M | Buy |
|
|||||
|
2018
Q2 | $3.57M | Buy |
|
|||||
|
2018
Q1 | $3.78M | Buy |
|
|||||
|
2017
Q4 | $3.98M | Buy |
|
|||||
|
2017
Q3 | $691K | Sell |
|
|||||
|
2017
Q2 | $686K | Buy |
|
|||||
|
2017
Q1 | $651K | Buy |
|
|||||
|
2016
Q4 | $467K | Buy |
|
|||||
|
2016
Q3 | $203K | Buy |
|
|||||
|
2016
Q2 | $80K | Buy |
|
|||||
|
2016
Q1 | $10K | Sell |
|
|||||
|
2015
Q4 | $10K | Sell |
|
|||||
|
2015
Q3 | $17K | Buy |
|
|||||
|
2015
Q2 | $16K | Buy |
|